Sunrest Lifescience IPO GMP, Review, Price, Allotment

The Sunrest Lifescience IPO date has been confirmed from November 7 and ended on November 9. Read the post to learn about Sunrest Lifescience IPO GMP.

Sunrest Lifescience is involved in the domestic marketing of OTC generic pharmaceutical goods. Sunrest Lifescience distributes a variety of pharmaceutical medicines made by outside producers. The corporation is present in these states through goods that are registered trademarks or that are pending registration.

Start your investing journey today. Find the latest information on Upcoming IPOs.

Key Details Of Sunrest Lifescience IPO:

Sunrest Lifescience GMP

The Sunrest Lifescience IPO GMP is ₹[5].

Sunrest Lifescience IPO Overview​

Sunrest Lifescience was placed on the stock market on November 20, 2023. The IPO was subscribed 48.54x. The last GMP for Sunrest Lifescience IPO was ₹5, updated on Nov 20th 2023 09:30 AM. As per the last GMP, the expected profit/loss for the IPO was 5.95%. Sunrest Lifescience IPO (SUNREST) had an issue price of ₹84.00 and was listed at ₹84, matching the allotted price by 0.00%. The Sunrest Lifescience IPO GMP is ₹[5]. According to the grey market, the predicted IPO launching price was ₹89, which is lower than the GMP pricing and considered a negative listing.

Sunrest Lifescience IPO Details

Sunrest Lifescience IPO Dates	7 – 9 November 2023
Sunrest Lifescience Issue Price	INR 84 per share
Fresh issue	1,291,200 shares (INR 10.85 crore)
Offer For Sale	Nil
Total IPO size	1,291,200 shares (INR 10.85 crore)
Minimum bid (lot size)	1,600 shares (INR 134,400)
Face Value	INR 10 per share
Retail Allocation	50%
Listing On	NSE SME

Sunrest Lifescience Financial Performance

	FY 2021	FY 2022	FY 2023	FY 2024
Revenue	16.95	26.89	24.64	5.64
Expenses	16.72	25.86	21.93	4.66
Net income	0.17	0.78	2.04	0.75

Sunrest Lifescience Valuations & Margins

	FY 2021	FY 2022	FY 2023
EPS	0.55	2.59	6.81
PE ratio	–	–	12.33
RONW (%)	56.12	72.49	65.59
NAV			10.38
EBITDA (%)	1.62	4.17	11.89
Debt/Equity	7.72	2.88	0.64

Sunrest Lifescience IPO Dates & Listing Performance

IPO Opening Date	7 November 2023
IPO Closing Date	9 November 2023
Finalization of Basis of Allotment	15 November 2023
Initiation of refunds	16 November 2023
Transfer of shares to demat accounts	17 November 2023
IPO Listing Date	20 November 2023
Opening Price on NSE SME	Coming soon
Closing Price on NSE SME	Coming soon

Company Profile​

Several outside manufacturers and one of its group companies support its commercial activities. Typically, Sunrest Lifescience interacts with pharmaceutical manufacturers via purchase orders or third-party manufacturing, depending on the customer’s needs.

IPO Strengths

• Experienced promoters and a competent management team.
• Well-established relationships with a loyal customer base.
• Access to markets worldwide, enabling global reach.

IPO Weakness

• Heavy reliance on customers based in the United States.
• Need to adhere to multiple laws and regulations in these countries to ensure compliance.
• Competition from other players in the market.

Sunrest Lifescience FAQs